Cargando…
The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats
The present study was designed to investigate the effect of once daily for 7-day (subchronic treatment) dosing of histamine H(3) receptor antagonists, ciproxifan (CPX) (3 mg/kg, i.p.), and clobenpropit (CBP) (15 mg/kg, i.p), including clozapine (CLZ) (3.0 mg/kg, i.p.) and chlorpromazine (CPZ) (3.0 m...
Autores principales: | Mahmood, D, Pillai, KK, Khanam, R, Jahan, K, Goswami, D, Akhtar, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556212/ https://www.ncbi.nlm.nih.gov/pubmed/26379444 http://dx.doi.org/10.4137/JEN.S27244 |
Ejemplares similares
-
Cardiovascular effects of H(3) histamine receptor inverse agonist/ H(4) histamine receptor agonist, clobenpropit, in hemorrhage-shocked rats
por: Wanot, Bartosz, et al.
Publicado: (2018) -
Ciproxifan, a histamine H(3) receptor antagonist, reversibly inhibits monoamine oxidase A and B
por: Hagenow, S., et al.
Publicado: (2017) -
Loss of Melanopsin Photoreception and Antagonism of the Histamine H3 Receptor by Ciproxifan Inhibit Light-Induced Sleep in Mice
por: Muindi, Fanuel, et al.
Publicado: (2015) -
Ciproxifan in preventing inhalational anesthetic-induced neurotoxicity!
por: Nair, Abhijit S.
Publicado: (2018) -
Hippocampal-Dependent Antidepressant Action of the H(3) Receptor Antagonist Clobenpropit in a Rat Model of Depression
por: Femenía, Teresa, et al.
Publicado: (2015)